| Goal |
Description |
Accountable |
Deliver By |
| Strategic Objective 1 |
Represent the association members of EFSPI and provide a united and respected voice on key scientific, regulatory and statistical issues in drug development |
| Financial |
Manage EFSPI budget and expenses
Review admin hours against contract
|
Birgitte
Birgitte/Admin |
Throughout year
End of each Qtr |
| Scientific meetings |
Deliver 3-4 Scientific meetings, including 1 webinar
Hold annual EFSPI meeting |
Egbert
Egbert |
EFSPI/BBS - HTA – 23rd June
~ 1 meeting every 3-4 months |
| Statistics Leaders meetings |
Arrange leaders meetings
Agree follow up actions
Write article for newsletter |
Stefan |
1st July 2015
Oct Council webex
Spet/Oct 2015 |
| Regulatory |
Support PSI/EFSPI Regulatory Committee, including review of new or updated regulatory guidance
Support EFSPI/PSI data transparency working group |
Christoph
Council |
Throughout year
Throughout year |
| Communications |
Effectively use website as a resource for information and resources
Distribute newsletters to communicate EFSPI activities and latest updates |
Chrissie/Francois
Chrissie |
Throughout year
Monthly newsletters |
| Strategic Objective 2 |
Enhance the profile of EFSPI in Europe and strengthen alliances and collaborations with other professional bodies within Europe |
| Enhance profile with EFPIA |
Seek opportunities on Clinical Development Committee to engage EFSPI in planned EFPIA activities
Support EFPIA Clinical Trial Design Taskforce |
Chrissie
Chrissie/Stefan |
Throughout the year
Throughout the year |
| Link to EMA Biostatistics working group |
Seek opportunities to engage on development of regulatory guidance documents, including face to face meeting (co-ordinated by Regulatory committee) |
Christoph |
Throughout the year |
| Partnerships between Special Interest Groups (SIGs) and other related associations |
Support SIGs to establish and/or maintain relationships with other important associations
Establish Rare Disease SIG to support ASTERIX |
Stefan with each SIG chair
Egbert |
Throughout the year
During 1H25 |
| Strategic Objective 3 |
Set and promote professional standards in Europe for the application, understanding and communication of statistics in drug development |
| Write position papers |
Identify topics for further position papers – aim to write at least 1 |
Council |
Throughout the Year
Data sharing a key topic |
| SIG best practices/manuscripts |
Identify best practice papers and/or manuscripts by each SIG
Help promote final reports/manuscripts |
Stefan
Council |
Throughout the Year
Throughout the Year |